Clinical Trials

138 enrolled

Extensive Stage Lung Small Cell Carcinoma

NCT05691478 2026-05-27

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

1,122 enrolled

Sarcoma

Osteosarcoma

NCT06780670 2026-05-27

PSMAcTION

443 enrolled

Prostatic Neoplasms

NCT07095452 2026-05-27

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

660 enrolled

Plasma cell

Multiple Myeloma

NCT07100080 2026-05-27

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

500 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07608224 2026-05-27

HOPE-07-MIBC

240 enrolled

Urinary Bladder Neoplasms

NCT04263025 2026-05-26

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

100 enrolled

Prostatic Neoplasms

NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Phase 2/3 Suspended

100 enrolled

Agnosia, Prostatic Neoplasms

NCT05987241 2026-05-26

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

992 enrolled

Muscle Invasive Bladder Urothelial Carcinoma

NCT06203600 2026-05-26

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

224 enrolled

Adenocarcinoma Of Esophagus

NCT07570173 2026-05-26

MK-1045-005

340 enrolled

Lymphoid

Burkitt Lymphoma

NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

422 enrolled

CNS

Advanced Glioblastoma

NCT04534205 2026-05-22

AHEAD-MERIT

350 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT04910685 2026-05-22

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

534 enrolled

Myeloid

Mastocytosis, Systemic

NCT05139017 2026-05-22

waveLINE-003

290 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05987956 2026-05-22

Drugs-SNPs

600 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06161025 2026-05-22

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

860 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06712316 2026-05-22

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

1,260 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07005102 2026-05-22

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

854 enrolled

Tumor-Agnostic

Neoplasms

NCT07462143 2026-05-22

A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

80 enrolled

Colonic Neoplasms

NCT07596290 2026-05-22

RADICAL

342 enrolled

Locally Advanced Rectal Adenocarcinoma

NCT07603349 2026-05-22

Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma

405 enrolled

Stomach Neoplasms

NCT04613596 2026-05-20

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

626 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06989437 2026-05-20

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

982 enrolled

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT07112196 2026-05-20

VINCIT

518 enrolled

Anorexia, Cachexia, Neoplasms, Weight Loss

NCT07365319 2026-05-20

TeLuRide-008

750 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07597941 2026-05-20

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Other hematologic neoplasm

60 enrolled

Leukemia, Promyelocytic, Acute

NCT07598318 2026-05-20

Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

164 enrolled

Cholangiocarcinoma

NCT02364557 2026-05-19

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

129 enrolled 23 charts

Breast

Breast Neoplasms, Lymphatic Metastasis

NCT02635009 2026-05-19

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

418 enrolled 52 charts

Extensive Stage Small Cell Lung Carcinoma

NCT07597070 2026-05-19

UNIFIER

1,200 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02438722 2026-05-18

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

174 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT03851445 2026-05-18

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

10,000 enrolled

Previously Treated Non-Small Cell Lung Cancer

NCT05096663 2026-05-18

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

82 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07063745 2026-05-18

MountainTAP-29

590 enrolled

Lung Neoplasms

NCT07585396 2026-05-18

Inositol in Letrozol Resistant PCOS Women

36 enrolled

Polycystic Ovary Syndrome

NCT03970447 2026-05-15

GBM AGILE

2,250 enrolled

CNS

Glioblastoma, Recurrence

NCT04765020 2026-05-15

POWER

56 enrolled

Motor Activity

NCT05255653 2026-05-15

RAINBO

1,615 enrolled

Gynecologic

Endometrial Neoplasms

NCT05889390 2026-05-15

NeoHTerMa

71 enrolled

Breast

Hyperthermia, Breast Neoplasms

NCT06193889 2026-05-15

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

66 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT07001748 2026-05-15

STOPGAP II

148 enrolled

Gynecologic

Peritoneal Neoplasms

NCT06788990 2026-05-14

FORTIFI-HN01

650 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Camurati-Engelmann Syndrome, Head and Neck Neoplasms, Laryngeal Diseases

NCT07129993 2026-05-14

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

630 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07221149 2026-05-14

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

690 enrolled

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT07241715 2026-05-14

CONVERGENCE

300 enrolled

Stomach Neoplasms

NCT07583888 2026-05-14

VABu Conditioning in Elderly AML HSCT

Other hematologic neoplasm

20 enrolled

Leukemia, Myeloid, Acute

NCT01810913 2026-05-13

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

613 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02339571 2026-05-13

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

600 enrolled

Dermatologic

Melanoma

NCT03984448 2026-05-13

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas